Latest American Homecare Federation News
Jun 24, 2015
- Tale of the Tape (Zacks) American Homecare Federation, a Diplomat Pharmacy, Inc. company (NYSE: DPLO ), announced its 2015 satisfaction survey results, receiving a 100 percent patient satisfaction rating for over 10 years in a row. Headquartered in Enfield, Connecticut, AHF is a specialty pharmacy that provides homecare pharmacy services to patients living with hemophilia, von Willebrand disease and other bleeding disorders. AHF has always taken great pride in the quality of services provided to the hemophilia community by providing assistance to patients in overcoming the medical, economic and societal barriers often faced by those living with hemophilia and other bleeding disorders. "Our families have always been our No. 1 priority here at AHF," said Mark Zatyrka, Director of Marketing at AHF. "I am so proud of the amazing team we have here at AHF. We will never stop fighting for whatever is best for our patients. " AHF was founded in 1989 by Donald Colburn and his wife, Kathy Keenan, who sought a solution to make home treatment of bleeding disorders easier to manage. The couple saw a need for a comprehensive, well-managed approach to treatment to ease the burden for families facing the same challenges. Since then, AHF has established itself as a leader in the bleeding disorders community, developing disease management programs for individuals and families that have significantly impacted and shaped the modern approach to patient care for these conditions. The company takes pride in not only providing the best possible care for their patients, but in supporting the bleeding disorders community as a whole. AHF provides significant annual donations to the Hemophilia Federation of America as well as many local and regional bleeding disorder organizations and foundations. Additional support is extended through scholarships, summer camp programs and volunteer hours from AHF staff members. To learn more about the services AHF provides, please visit www.AHFinfo.com or call 800.243.4621. © 2015 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.